利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

48 条记录 (耗时 0.036 秒)

    Metabolic gene polynucleotides and polypeptides and uses thereof
    2.
    发明授权
    Metabolic gene polynucleotides and polypeptides and uses thereof 失效
    代谢基因多核苷酸和多肽及其用途

    公开(公告)号：US07348406B2

    公开(公告)日：2008-03-25

    申请号：US10466376

    申请日：2002-01-15

    申请人： Mary Ruth Erickson ,  Barbara A. Chicca ,  Bernard Bihain ,  Hiroaki Tanaka

    发明人： Mary Ruth Erickson ,  Barbara A. Chicca ,  Bernard Bihain ,  Hiroaki Tanaka

    IPC分类号： C07K14/00 ,  C07K16/00 ,  A61K38/00

    CPC分类号： A61K38/1709 ,  A01K2217/05 ,  A01K2217/075 ,  C07K14/47

    摘要： The present invention relates to the field of metabolic research. Metabolic disorders, such as obesity, are a public health problem that is serious and widespread. GMG-3, GMG-4, Cluster 1, GMG-6A, or GMG-6B polypeptides have been identified that are beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing body mass and for treating metabolic-related diseases and disorders. These metabolic-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.

    摘要翻译： 本发明涉及代谢研究领域。 代谢紊乱，如肥胖，是一个严重而广泛的公共卫生问题。 已经鉴定出有益于治疗代谢紊乱的GMG-3，GMG-4，簇1，GMG-6A或GMG-6B多肽。 这些化合物应该有效减少体重和治疗与代谢有关的疾病和病症。 这些代谢相关的疾病和病症包括高脂血症，动脉粥样硬化，糖尿病和高血压。

    Metabolic gene polynucleotides and polypeptides and uses thereof
    4.
    发明申请
    Metabolic gene polynucleotides and polypeptides and uses thereof 失效
    代谢基因多核苷酸和多肽及其用途

    公开(公告)号：US20060247160A1

    公开(公告)日：2006-11-02

    申请号：US10466376

    申请日：2002-01-15

    申请人： Mary Ruth Erickson ,  Barbara Chicca ,  Bernard Bihain ,  Hiroaki Tanaka

    发明人： Mary Ruth Erickson ,  Barbara Chicca ,  Bernard Bihain ,  Hiroaki Tanaka

    IPC分类号： A61K38/22

    CPC分类号： A61K38/1709 ,  A01K2217/05 ,  A01K2217/075 ,  C07K14/47

    摘要： The present invention relates to the field of metabolic research. Metabolic disorders, such as obesity, are a public health problem that is serious and widespread. GMG-3, GMG-4, Cluster 1, GMG-6A, or GMG-6B polypeptides have been identified that are beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing body mass and for treating metabolic-related diseases and disorders. These metabolic-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.

    摘要翻译： 本发明涉及代谢研究领域。 代谢紊乱，如肥胖，是一个严重而广泛的公共卫生问题。 已经鉴定出有益于治疗代谢紊乱的GMG-3，GMG-4，簇1，GMG-6A或GMG-6B多肽。 这些化合物应该有效减少体重和治疗与代谢有关的疾病和病症。 这些代谢相关的疾病和病症包括高脂血症，动脉粥样硬化，糖尿病和高血压。